DOACs in the Anticoagulant Treatment Landscape

(16:9)

Direct-Acting Oral Anticoagulants (DOACs) | MOA , Indications, Adverse Reactions, Contraindications

(27:51)

DOACs in Elderly Patients and Extremes of Weight

(44:40)

DOACs in Adolescents

(28:54)

DOACs vs Warfarin - WHEN TO USE ONE vs THE OTHER

(13:45)

The Evolving Role of DOACs in the Management of Venous and Arterial Disease

(46:19)

DOACs in extremes of body weight

(58:43)

DOACs in cancer associated thrombosis: Sub-group challenges and considerations

(1:14:16)

DOACs in Renal Dysfunction and Liver Disease

(37:41)

DOACs: Anticoagulation Principles - Part 1: Background, Mechanism, and Uses

(19:7)

DOACs for the prevention and acute treatment of CAT - Video abstract [ID 271411]

(3:31)

Challenges of using DOACs in everyday practice - CardioEd Lecture

(1:14)

Dr. Nagalla on the Utility of DOACS in Cancer-Associated Thrombosis

(1:22)

Direct Oral Anticoagulants: Impact \u0026 Interference of DOACs on Coagulation Testing

(15:13)

Dr. Nagalla on Need for Timely Assays for DOACs in MPNs

(1:38)

Understanding DOACS and major bleed risks: the crucial conversation to have with your doctor

(6:)

Use of DOACs in Kidney Patients - BC Renal Province-wide Rounds (Oct 2019)

(56:22)

Direct Thrombin Inhibitors and Factor Xa Inhibitors (DOACs) - Pharmacology - Hematology

(7:21)

Using Real-World Evidence to Compare DOACs for Stroke Prevention in Patients With NVAF

(29:11)

Apixaban edges other DOACS for octogenarians

(1:5)